Copyright
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 110087
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.110087
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.110087
Table 1 Patients demographics
Luminal A (n = 82) | Luminal B (n = 12) | Triple neg (n = 8) | HER 2 enrich (n = 5) | P value | |
Age at diagnosis | 59.8 ± 12.4 | 58.7 ± 11.65 | 62.2 ± 15.8 | 56.21 ± 11.0 | 0.85 |
Metastasis-free survival (median, years) | 2.55 (0.05-7.39) | 2.75 (0.65-7.12) | 1.14 (0.09-5.98) | 0.37 (0.05-8.89) | 0.98 |
BMI | 26.8 ± 5.9 | 24.4 ± 5.7 | 26.3 ± 4.8 | 25.4 ± 8.3 | 0.58 |
Death | 59 (72.8%) | 9 (75%) | 8 (100%) | 3 (60%) | 0.33 |
Table 2 Anatomical distribution of first bone metastasis according to histological subtypes, n (%)
First bone metastasis | Luminal A (n = 82) | Luminal B (n = 12) | Triple neg (n = 8) | HER 2 enrich (n = 5) | P value |
Skull bones | 3/82 (3.7) | 0 | 1/8 (12.5) | 0 | 0.5 |
Scapula and clavicle | 3/82 (3.7) | 1/12 (8.3) | 3/8 (37.5) | 0 | 0.003 |
Sternum | 7/82 (8.5) | 2/12 (17) | 1/8 (12.5) | 2/5 (40) | 0.16 |
Humerus | 14/82 (17) | 2/12 (17) | 1/8 (12.5) | 0 | 0.77 |
Ribs | 24/82 (30) | 2/12 (17) | 1/8 (12.5) | 4/5 (80) | 0.041 |
Cervical vertebra | 12/82 (15) | 3/12 (25) | 1/8 (12.5) | 0 | 0.60 |
Thoracic vertebra | 36/82 (44) | 5/12 (45.5) | 2/8 (25) | 3/5 (60) | 0.64 |
Lumbar vertebra | 38/82 (46) | 7/12 (58) | 3/8 (37.5) | 2/5 (40) | 0.79 |
Sacrum | 18/82 (22) | 1/12 (8) | 1/8 (12.5) | 1/5 (20) | 0.68 |
Pelvic bones (ilium, ischium, pubis) | 43/82 (52) | 5/12 (42) | 5/8 (62.5) | 3/5 (60) | 0.80 |
Femoral head and neck | 21/82 (26) | 4/12 (33) | 2/8 (25) | 3/5 (60) | 0.39 |
Femoral shaft and distal femur | 20/82 (25) | 3/12 (25) | 2/8 (25) | 3/5 (60) | 0.38 |
Table 3 Anatomical distribution of second bone metastasis according to histological subtypes, n (%)
Second bone metastasis | Luminal A (n = 82) | Luminal B (n = 12) | Triple neg (n = 8) | HER 2 enrich (n = 5) | P value |
Without bone progression | 16/82 (19.5) | 3/12 (25) | 3/8 (37.5) | 1/5 (20) | 0.68 |
Skull bones | 7/82 (9) | 0 | 0 | 0 | 0.50 |
Scapula and clavicle | 6/82 (7) | 1/12 (8) | 1/8 (12.5) | 0 | 0.36 |
Sternum | 7/82 (9) | 0 | 0 | 0 | 0.50 |
Humerus | 10/82 (12.5) | 2/12 (17) | 2/8 (25) | 0 | 0.60 |
Ribs | 28/82 (35) | 2/12 (17) | 0 | 1/5 (20) | 0.13 |
Cervical vertebra | 19/82 (24) | 3/12 (25) | 1/8 (12.5) | 1/5 (20) | 0.90 |
Thoracic vertebra | 35/82 (44) | 3/12 (25) | 2/8 (25) | 2/5 (40) | 0.50 |
Lumbar vertebra | 28/82 (35) | 6/12 (50) | 2/8 (25) | 0 | 0.24 |
Sacrum | 17/82 (21) | 3/12 (25) | 0 | 1/5 (20) | 0.53 |
Pelvic bones (ilium, ischium, pubis) | 31/82 (38) | 7/12 (58) | 0 | 3/5 (60) | 0.046 |
Femoral head and neck | 25/82 (31) | 2/12 (17) | 3/8 (37.5) | 1/5 (20) | 0.68 |
Femoral shaft and distal femur | 24/82 (30) | 2/12 (17) | 2/8 (25) | 1/5 (20) | 0.77 |
Table 4 Pathologic and impending fractures according to histological subtypes, n (%)
Pathological fracture | Luminal A (n = 82) | Luminal B (n = 12) | Triple neg (n = 8) | HER 2 enrich (n = 5) | P value |
Femoral head and neck | 16 (20) | 4 (33) | 2 (25) | 1 (20) | 0.75 |
Spinal vertebrae | 12 (15) | 1 (8) | 0 | 1 (20) | 0.77 |
Humerus | 5 (6) | 1 (8) | 1 (12.5) | 0 | 0.78 |
Other1 | 8 (10) | 0 | 1 (12.5) | 0 | 0.63 |
Impending hip fracture | 29 (35) | 6 (50) | 3 (37.5) | 0 | 0.28 |
Table 5 Anatomical distribution of first bone metastasis according to hormone receptor, n (%)
First bone metastasis | ER (n = 94) | PR (n = 59) | HER 2 (n = 16) | P value |
Skull bones | 3/94 (3.2) | 1/59 (1.7) | 0 | 1.00 |
Scapula and clavicle | 4/94 (4.2) | 3/59 (5) | 1/16 (6.2) | 0.93 |
Sternum | 9/94 (9.6) | 5/59 (8.5) | 4/16 (25) | 0.14 |
Humerus | 16/94 (17.0) | 10/59 (16.9) | 2/16 (12.5) | 0.89 |
Ribs | 26/94 (28.0) | 14/59 (24.1) | 6/16 (37.5) | 0.56 |
Cervical vertebra | 15/94 (16.0) | 10/59 (16.9) | 3/16 (18.8) | 0.96 |
Thoracic vertebra | 41/94 (43.6) | 23/59 (38.9) | 8/16 (50) | 0.62 |
Lumbar vertebra | 45/94 (47.9) | 25/59 (42.4) | 8/16 (50) | 0.76 |
Sacrum | 19/94 (20.2) | 10/59 (16.9) | 2/16 (12.5) | 0.72 |
Pelvic bones (ilium, ischium, pubis) | 48/94 (51.1) | 27/59 (45.8) | 8/16 (50) | 0.81 |
Femoral head and neck | 25/94 (26.6) | 18/59 (30.5) | 7/16 (43.8) | 0.37 |
Femoral shaft and distal femur | 23/94 (24.7) | 16/59 (27.6) | 6/16 (37.5) | 0.56 |
- Citation: Zari DS, Novak R, Haviv O, Ron I, Kaplan B, Awad B, Norman D, Nikomarov D. Anatomical distribution of bone metastases in stage IV breast cancer: According to histological subtype. World J Clin Oncol 2025; 16(9): 110087
- URL: https://www.wjgnet.com/2218-4333/full/v16/i9/110087.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i9.110087